Anthrax

Anthrax
CDC/ James H. Steele · Public domain · source
Name	Anthrax
Field	Infectious disease, Bacteriology
Symptoms	Fever, chest pain, skin ulcers, respiratory distress
Complications	Septicemia, meningitis, respiratory failure
Onset	Variable
Duration	Days to weeks
Causes	Bacillus anthracis
Risks	Occupational exposure (veterinary, agricultural), bioterrorism
Diagnosis	Culture, polymerase chain reaction, immunoassays
Prevention	Vaccination of livestock, human vaccines for risk groups, protective equipment
Treatment	Antibiotics (ciprofloxacin, doxycycline), antitoxins, supportive care
Deaths	Variable by form and treatment

Anthrax Anthrax is a zoonotic infectious disease caused by Bacillus anthracis affecting humans, mammals, and other animals. It presents in cutaneous, inhalational, gastrointestinal, and injection forms and has been implicated in natural outbreaks, industrial exposures, and deliberate releases. The disease has shaped policies in public health, biodefense, veterinary medicine, and international law through interactions with institutions such as the World Health Organization, Centers for Disease Control and Prevention, and the United Nations.

Overview

Anthrax involves a spore-forming, gram-positive rod that persists in soil and can infect herbivores such as cattle, sheep, and goats, with secondary zoonotic transmission to humans via contact with contaminated animal products or aerosols. Control strategies link veterinary public health, agricultural regulation, and trade bodies like the Food and Agriculture Organization and national ministries such as the United States Department of Agriculture and the Department of Health and Human Services. The socioeconomic impact of outbreaks has affected regions including Sub-Saharan Africa, Central Asia, and parts of South America, while historical events in Europe and North America have informed modern surveillance systems.

Causes and Microbiology

The etiologic agent, Bacillus anthracis, is distinguished by virulence determinants encoded on plasmids, including the protective antigen, lethal factor, and edema factor, which compose the anthrax toxin complex studied in laboratories at institutions such as the National Institutes of Health, Rocky Mountain Laboratories, and university research centers. Spores result from sporulation under environmental stress and resist heat, desiccation, and many disinfectants; this trait has made spores central to regulatory frameworks under the Biological Weapons Convention and biosafety guidance from agencies like the European Centre for Disease Prevention and Control. Genomic analyses at centers including the Wellcome Sanger Institute and the Los Alamos National Laboratory have traced lineages relevant to epidemiology and forensic investigations involving law enforcement agencies such as the Federal Bureau of Investigation.

Transmission and Epidemiology

Transmission occurs via inoculation of spores into skin abrasions, inhalation of aerosolized spores, ingestion of contaminated meat, or injection of contaminated drugs—a concern highlighted in outbreaks linked to intravenous drug use treated by public health authorities like local departments of health and addiction services. Occupational exposures have implicated sectors regulated by the Occupational Safety and Health Administration and industries in cities with historical leatherwork and textile mills. Notable epidemiologic investigations have involved collaborations among the Centers for Disease Control and Prevention, national public health institutes, military research units, and nongovernmental organizations during responses in countries such as Kenya, India, and Russia.

Clinical Manifestations and Diagnosis

Cutaneous anthrax classically begins as a painless papule progressing to an eschar with surrounding edema; inhalational anthrax presents with nonspecific flu-like symptoms progressing to severe respiratory compromise and mediastinal widening on imaging, noted in clinical reports from hospitals like Massachusetts General Hospital and university medical centers. Gastrointestinal anthrax follows ingestion of contaminated meat and may present with severe abdominal pain and hemorrhagic enteritis, whereas injection-related disease has produced severe soft-tissue infections in affected regions. Diagnosis employs microbiology laboratories using culture and staining, molecular assays such as polymerase chain reaction deployed by reference centers including the European Molecular Biology Laboratory, and immunologic testing used by clinical laboratories within hospital networks. Clinical management often requires coordination among intensive care units, infectious disease specialists, and surgical teams in tertiary referral centers.

Treatment and Prevention

Treatment combines antimicrobials—commonly recommended agents like ciprofloxacin and doxycycline—antitoxin therapies developed through collaborations among pharmaceutical companies, academic centers, and regulatory agencies such as the Food and Drug Administration, and supportive care in intensive care settings. Prevention relies on veterinary vaccination programs administered through agricultural ministries, human preexposure vaccines offered to at-risk cohorts including military personnel from forces like the United States Army and laboratory workers, and public health measures such as carcass disposal and surveillance coordinated by international networks like the Global Outbreak Alert and Response Network. Policy responses have invoked legal frameworks including national public health laws and international agreements overseen by bodies such as the World Organisation for Animal Health.

History and Notable Outbreaks

Anthrax has historical significance from antiquity to modern times, influencing trade and medical thought in regions under the Roman Empire and through writings by physicians such as Hippocrates and commentators in medieval Europe. The disease featured in 19th-century studies by scientists at institutions like the Pasteur Institute and Koch's laboratory, contributing to the germ theory and the development of vaccines by pioneers associated with Louis Pasteur and Robert Koch. Notable 20th- and 21st-century events include industrial outbreaks in textile centers, epizootics in parts of Africa and Asia, and the 2001 letters-based incidents in the United States that engaged agencies such as the Federal Bureau of Investigation and prompted legislation in the United States Congress. More recent outbreaks have involved coordinated responses by ministries of health, international partners, and nongovernmental organizations in affected countries, spurring advancements in biosurveillance, emergency preparedness, and One Health initiatives linking human and animal health sectors.

Category:Infectious diseases